E-selectin is an inducible endothelial cell adhesion protein that is a critical element in the binding of leukocytes to activated endothelial cells. It is induced by a variety of proinflammatory soluble substances including interleukin-l (IL-l), tumor necrosis. factor ~TNF), or bacteriallipopol,Ysaccharide (LPS). III Vitro studles of large vessel endothelIal cells demonstrate that stimulation with TNF or IL-l leads to a rapid, but transient, induction of E-selectin expression that disappears within 24 hours. However, ill vivo studies have shown that microvascular endothelial cells persistently express E-selectin in chronic inflammatory states, particularly in the skin where it serves as a homing receptor for memory T cells. Stimulation of dermal-derived microvascular endothelial cells (HDMECs) with single doses ofIL-l a, TNF a, or LPS resulted in transient but slightly more persistent expression of E-selectin than seen after stimulation of large vessel derived umbilical vein endothelial cells (HUVECs). However, stimulation of either HDMECs or HUVECs with re-E -selectin or endothelial leukocyte adhesion molecule 1 (ELAM-l) is an inducible endothelial cell (Ee) surface glycoprotein [1] [2] [3] [4] . It is a member of the selectin family of adhesion proteins and bears structural similarities to L-selectin (leukocyte adhesion molecule 1, LAM-1) on leukocytes and P-selectin on platelets and EC (GMP 140, PAGEM, CD62) [5) . Although E-selectin was originally described as an adhesion molecule mediating the binding of neutrophils and monocytes, more recently it has been shown to mediate the binding of memory T lymphocytes and tumor cells to ECs [6] [7] [8] . Furthermore, E-selectin appears to serve as an important ligand for the homing ofT lymphocytes specificall y to sites of cutaneous inflammation [6, 9) .
The expression of E-selectin has been studied extensively on human umbilical vein ECs (HUVECs) . Although not constitutively expressed on HUVECs, E-selectin expression can be induced by treatment with interleukin 1 (IL-1), tumor necrosis factor (TNF), and bacterial lipopolysaccharide (LPS) [1, 2, 10) . Unlike the cytokine induction of intercellular adhesion molecule 1 or vascular cell adhesion molecule 1, the induced expression ofE-selectin has been reported to be transient on HUVECs, peaking after 6 -8 h of stimulation and returning to baseline by 24 h [1, 2) . HUVECs are refracManuscript received September 9, 1993 ; accepted for publication November 12,1993 .
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petitive doses of IL-la, TNFa, or LPS in the presence of human serum or plasma resulted in persistent E-selectin expression in vitro. The persistent E-selectin cell surface expression was associated with persistent E-selectin mRNA expression and correlated with E-selectin -mediated HL-60 binding to endothelial cell monolayers. The effect of human plasma or serum was dose dependent, and fractionation of human plasma by gel filtration demonstrated that the E-selectin persistence activity resolved into high and low molecular peaks. These data demonstrate that human endothelial cells are capable of persistent E-selectin expression ill vitro and that factors in human serum or plasma are critical in preventing cytokine refractoriness and loss of E-selectin expression. This study provides a basis to resolve the apparent discrepancies between previous in VillO and in vitro dynamics ofE-selectin expression. 445 -450, 1994 tory to reinduction of E-selectin by the same stimulus prior to a requisite recovery period of 12 h [1 ,2) . These kinetics are not consistent with observations of the in vivo expression of E-selectin in chronic inflammation, where E-selectin may be persistently expressed [11] [12] [13] .
We have previously examined the expression of inducible and constitutively expressed proteins on large-vessel HUVECs and small-vessel ECs derived from the dennis of human foreskin (HDM.Ee) and found that smalI-vessel ECs differ significantly both phenotYpically and functionalI y [14] [15] [16] . Because the microvascular ECs of the dermis are critical in the regulation of leukocyte traffic into the skin, we have examined the expression of E-selectin in HD MECs and compared it to the regulated expression of E-selectin on HUVECs. We have determined that persistent expression of E-selectin can be induced on either HDMECs or HUVECs in vitro by repetitive stimulation with cytokine in the presence of human plasma or serum.
MATERIALS AND METHODS
Isolation and Culture ofHDMECs HDMECs were isolated by from human foreskins by trypsinization and percoll gradient centrifugation by a previously described technique [14] [15] [16] . Cel ls were cultured in media (HDMEC media) consisting of MCDB 131 (Clonetics Corp., San Diego, CA), 30% normal human serum (NHS, Irvine Scientific, Santa Ana, CA), epider~aj growth factor (5 ng/ ml, Clonetics), hydrocortisone acetate (1 Jlg/mj, Sigma C hemical, St. Louis, MO), dibutyryl cyclic AMP (5 X 10-5 M, Sigma), 100 U /ml penicillin (Irvine), 100 Jlg/ ml streptomycin (Irvine), 10 Jlgjwl ciprofloxacillin (Miles Pharmaceuticals, West Haven, CT), and 250 Jlg/ml amphotericin B (Irvine). The resulting cell cultures were consistently 100% pure as assessed by morphologic and immunochemical criteria [14] [15] [16] Induction of E-selectin Expression on HDMECs or HUVECs and Measurement by Enzyme-Linked Immunosorbent Assay (ELISA) HDMECs or HUVECs were plated in 96-well plates and allowed to grow to confluence over 24 h. Cells were then stimulated with TNFa (1-100 U/ml; Genentech, South San Francisco. CAl. IL-la (1 -100 U Iml; Dr. Ira Green, NIH). or LPS (1 -1000 ng/ml; Sigma). For time course studies. appropriate wells were stimulated with a single dose of IL-lcx. TNFa. or LPS sequentially and then assayed simultaneously at the conclusion of the time course. For studies utilizing repetitive doses of cytokine. the old media was removed and fresh media was added to stimulated we lls at each successive time point. For example. cell s initially stimulated for a 48-h time point were refed fresh media with cytokine 24 h later. when the next group of cells were stimulated for the 24-h time point. This process was repeated for the 16-.6-. Isolation of Total Cellular for Northern Blot Analysis "!'otal cellular RNA was isolated from experimental cells by guanidinium isothiocyanate lysis and CsCI density gradient pelleting [20] . Equal quantities of RNA samples were fractionated over formaldehyde/agarose gels. transferred to nylon membranes (Nytran; Schleicher & Schull. Keene. NI-l). and then ultraviolet (UV) cross-linked to membranes using an automated UV exposure device (Stratagene. La Jolla. CAl· Membranes were pre hybridized at 42°C for 1 h or longer in a solution of 50% formamide, 1 M NaCI, 10% dextran sulfate. 1 % sodium dodecyl sulfate (SDS), and 200 ).lg/ml yeast tRNA. Membranes were hybridized overnight at 42°C with 20 ng of randomly primed 32P-Iabeled cDNA fragments for the E-selectin. gene [21] (Dr. T . Venkat Gopal, Otsuka America Pharmaceuticals, Rockville, MD, specific activities 10 8 -1 0 9 cpm/ Jlg). Probed membranes were washed under increasingly stringent conditions and exposed to x-ray film (Hyperfilm; Amersham) with one intensifying screen at -70°C for varying till1e5."Following hybridization with specific cDNA probes, membranes were stripped and rehybridized with a p-actin cDNA fragment to assess uniformity of RNA loading and transfer.
HL-60 Binding Assay The human leukemia line HL-60 was obtained from Dr. Ed Ades (CDC. Atlanta, GA) and was maintained in RPMI 1640
• MoAbs E.12F9 and 1 D6 immunoprecipitate E-selectin from E-sclectin transfected, but not mock transfected COS cel ls. Dr. Barry Wolitzky, personal communication.
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY with 10% FCS, 2 mM glutamine, 100 U/ml penicillin, 100 Jlg/ml streptomycin, and 250 Jlg/ml amphotericin B. HL-60 were radiolabeled by incubation of 5 X 10 7 cells in 20 ml of media with 200 uCi of 51Cr overnight at 37°C with 5% CO 2 , HDMECs were plated in 48-well tissue culture plates and stimulated for 1-48 h with 100Jl/ml IL-la.ln some experiments, fresh cytokine was added to previously stimulated wells at each subsequent time point (as described above). After stimulation. ECs were washed once with HBSS with divalent cations and 10% FCS and 50 Jll of the same media containing 2-4 X 10 4 radiolabe led HL-60 were added to each well. For antibody blocking experiments, HDMECs were pre incubated with MoAb prior to the addition of HL-60 cells. MoAb 7 A9 recognizing E-selectin was used at 5 Jlg/ml. Ascites containing MoAb W6/32 (recognizing MHC class I) or MoAb 84HI0 (recognizing ICAM-l) were used at a 1: 100 dilution. After incubation with HL-60 cells for 30 min at 37°C with 5% C02, the plates were washed twice, 50 Jll of 10% SDS was added to each well, and the contents of each well were harvested with a cotton swab and counted in a y counter (Beckman G5500). The percent binding was calculated as follows:
cpm added counts -background cpm Fractionation of Human Plasma by Gel Filtration Human plasma was obtained from normal volunteers by venipuncture after informed consent according to the guidelines of the Emory University Institutional Review Board. Venous blood was heparinized with 100 U/ml of bovine heparin (Upjohn, Kalamazoo, MI), centrifuged. and the plasma decanted and saved. Five milliliters of heparinized plasma was loaded on a Sephacryl S-200 column (Pharmacia, Uppsala, Sweden, 1.5 X 70 cm, total bed volume 105 mI) that had been pre-equilibrated with HBSS with 1 U/ml of heparin sodium, divalent cations, and 5 X antibiotics, and 2-ml fractions were collected. The activity of individual column fractions was assessed for its ability to facilitate IL-1a -induced persistent E-selectin expression. HUVECs were stimulated repetitively for 48 h with equal parts media containing 200 U /ml of IL-la and selected column fractions . After 48 h, the expression of Eselectin was assessed by ELISA as described above. The protein concentration of each fraction was estimated by determining the OD 280 of the residual unused portion of each fraction.
RESULTS
Induction ofE-selectin on HDMECs and HUVECs with Single Cytokine Doses Unstimulated HDMECs or HUVECs did not express cell surface E-selectin. Stimulation of HDMECs or HUVECs with a single dose of IL-1a (100 U/ml), TNFa, (100 U /ml), or LPS (1 ).lg/ml) for 6 h induced the expression ofE-selectin when assessed by ELISA or flow cytometric analysis (data not shown). Maximal E-selectin expression was induced by 50-100 U/ml ofIL-la or TNFa, and 100 ng/ml ofLPS. Minimal induction ofE-selectin was seen on HDMECs (Fig lA) or HUVECs (Fig  lB) after 1 h of stimulation with a single dose of IL-la or TNFa, but significant expression was always evident after 4 h. Maximal expression was observed in both HDMECs and HUVECs after 6 h of stimulation. E-selectin expression on HUVECs decreased markedly after 16 h and returned to baseline after 24 h . In contrast, maximal or near-maximal levels of E-selectin expression were clearly evident on HDMECs after 16 h. Expression ofE-selectin on HDMECs was variable after 24 h of stimulation with IL-la or TNFcx, but E-selectin expression was consistently near baseline 48 h after stimulation with a single dose of IL-l cx or TNFa.
Induction of Persistent E-selectin Expression on HDMECs with Multiple Cytokine Pulses Because of the puzzling discrepancy between transient ill vitro expression and persistent itl vivo expression of E-selectin in cutaneous inflammation, we examined whether persistence of E-selectin expression could be induced on microvascular ECs ill vitro by repetitive dosing with cytokines. We compared the expression of E-selectin on HDMECs stimulated with a single dose of cytokine to the expression on an experimental group of HDMECs repetitively treated with fresh cytokine at each time point (Fig 2) . In these experiments, maximal levels ofE-selectin expression in cells stimulated with a single dose of IL-la were seen after 6 h of stimulation. E-selectin expression fell markedly after 24 h, and was essentially undetectable after 48 h. However, HDMECs stimulated with repetitive doses of IL-lcx demonstrated open circles) or TNFa (100 U I ml , closed circles) and E-sclectin expression was assessed by ELISA after I , 4, 6, 16, 24 , and 48 h of stimul ation.
maximal levels ofE-selectin, which clea rly persisted at 48 h. Repetitive stimulatio n of HDMECs with TN Fa or LPS also induced E-selectin expressio n, which persisted at least 48 h (data no t shown) .
In selected experiments, E-selectin expression was assayed and fo und still to be max imal 72 h after either IL-la, TNFa, or LPS stimul ati o n (data not shown) . B ecause repetitive doses of cytokine were capable of inducing persistent E-selectin expression, the transient expression of E-selectin after a single cytokine dose suggested that the fall in E-selectin levels m ay be due to loss of cytokine activity or clearance of cytokine by the endothelial cell monol ayers. T o investigate th ese possibilities, w e stimulated HDMECs with either fresh IL-l a, IL-la that had been incubated with HDMECs for 24 h, or IL-l a that had been incubated in microtiter plates without HDMECs at 3r c for 24 h (Fig 3) . Incubatio n of cytokine with HDMECs resulted in grea ter than 80% loss of E-selectin-inducing activity, compared to fres h IL-la. In contrast, IL-la incubated withollt HDMECs demo nstrated activity comparable to fres h cy tokine. These data suggest that endothelial cells inactivate or clear IL-la activity from the media, resulting effectively in a single pulse of stimulatio n rather than continuo us prese nce of the activating cytokine.
N orthern Blot Analysis ofHDMECs Stim.ulated with Single or Multiple Doses ofIL-la (Fig 4) W e explored whether persistence of surface E-selec tin on HDMECs with repetiti ve doses of cell binding to microvascular ECs, we examined the binding of the HL-60 cells to cytokine-stimulated HDMECs. HL-60 cells have been previously shown to adhere to activated endothelial cells via an E-selectin-dependent mechanism [1, 2] and MoAb-blocking studies clearly demonstrated that HL-60 cells bind to activated HDMECs via an E-selectin-dependent mechanism (Fig SA) . Furthermore, the binding of HL-60 cells paralleled the expression of E-selectin on HDMECs (Fig SB) . Binding of HL-60 increased three-to five-fold after IL-1a stimulation and was maximal after 6 h after a single cytokine dose. The elevated binding persisted at maximal · or near-maximal levels for 16 h and then fell back to baseline levels by 48 h. Treatment of HDMECs with repetitive cytokine doses resulted in persistently increased levels of HL-60 binding to HDMECs up to 48 h, which correlated with the persistent expression of E-selectin.
Induction of Persistent E-Selectin Expression on HUVECs
The induction and regulation of E-selectin on large-vessel-derived HUVECs has been extensively studied [1 ,2] . These studies demonstrated that after cytokine stimulation, HUVECs exhibit a refractory period where E-selectin cannot be reinduced by the same cytokine. Repetitive stimulation of HUVECs with IL-1a (100 U/ml) failed to induce persistent E-selectin expression (Fig 6A,B) . However, when HUVECs were grown in HDMEC media or HUVEC media supplemented with human serum and stimulated with repetitive doses ofIL-1a, E-selectin expression was induced and persisted in a manner identical to that seen with HDMECs (Fig 6A) . These data demonstrate that human serum provides a signal that is required for persistent IL-1 -induced expression of E-se\ectin by both microvascular and large-vessel ECs. Further studies determined that the activity was present in both human serum and plasma (Fig 6B) . Also, HUVECs stimulated with IL-1a persistently expressed E-selectin when stimulated in the presence of both FCS and human plasma or serum, demonstrating that FCS did not contain a factor that inhibited E-selectin expression (data not shown). The activity was dose dependent, with maximal E-selectin persistence noted after repetitive stimulation with cytokine in the presence of at least 30-50% human plasma (Fig 7) . To further characterize the nature of the factor in human plasma that is responsible for the E-selectin persistence, we fractionated human plasma by gel filtration on Sephacryl S-200 and examined the activity of the collected fractions (Fig 8) . HUVECs were stimulated with repetitive doses of IL-la (100 U Iml) in combination with serum fractions and examined for E-selectin expression after 48 h. Two peaks of E-selectin persistence activity were observed. The first peak was seen in the void volume of the column, suggesting a molecular weight greater than 200,000. A second broad peak was seen after the majority of the protein has passed through the column. Sizing of the column demonstrated that this peak sized between ovalbumin (MW 45,500) and ribonuclease (MW 13,500). DISCUSSION E-selectin is an important endothelial-specific adhesion molecule that may mediate the binding of a variety of bone marrow-derived cells to activated ECs [2, 6] . E-selectin was originally described as an inducible protein on umbilical vein-derived ECs that was rapidly induced, transiently expressed, and supported the binding of neutrophils to activated endothelium [3J . The induction of EC Eselectin in cutaneous inflammation in vivo was associated with neutrophilic inflammatory cell infiltrates [1 2] . The kinetics ofE-selectin expression and its affi nity for neutrophils were felt to be consistent with its role in mediating neutrophil binding early in the evolution of acute inflammation. More recent observations suggest that this scenerio is not adequate to explain the role of E-selectin in inflammation. Immunohistochemical studies of chronic cutaneous and synovial inflammation clearly demonstrate that E-selectin is persistently expressed [12, 13] . These ill vivo studies are difficult to reconcile with i/l vitro observations demonstrating that E-selectin can only be transiently induced on ECs in culture. Additionally, E-selectin has also been shown to mediate the binding of leukocytes other than neutrophils. In particular, memory T lymphocytes are able to bind to E-selectin and E-selectin may function as a homing receptor for specific resting meInory T-cell subsets, directing their localization to cutaneous inflammatory sites [6, 7, 9] .
The original ill vitro studies of the expression of E-selectin demonstrated that it was only transiently expressed despite the apparent continuous presence of cytokines [1, 2] . Furthermore, experiments using multiple cytokine pulses demonstrated the presence of a refractory period in which E-selectin could not be induced by the saIne cytokine without a requisite recovery period of 12 h [1 ,2] . IFN -y has been shown to nominally prolong the expression of Eselectin on HUVECs in vitro, although in these studies the expression of E-selectin still fell to near baseline after 48 h [23] . Furthermore, subsequent studies suggested that IFN-y augments cytokineinduced E-selectin expression and also inhibits the refractory period after LPS stimulation, although data regarding the refractory period after IL-l and TNF stimulation were not presented [23] . The persistent responsiveness to cytokine stimulation that we observed itl vitro correlates with in villo observations of E-selectin expression in chronic inflammation. Our data demonstrate that under the correct in vitro conditions, E-selectin can be induced and its expression and function will chronically persist at essentially maximal levels on ECs in culture. This persistence is not due to inherent differences in ECs derived from different vascular beds, as has been described with VCAM-l and CD36 [15, 16] . Persistent E-selectin expression requires both repetitive cytokine stimulation and, additionally, persistent expression depends upon the growth of EC:s in.media containing hU~1an serum or plasm~. Repetitive stimulation IS necessary because smgle doses of cytokmes appear rapidly cleared or inactivated by ECs. It is likely that the inflammatory cells characteristically found at sites of chronic inflammation in the skin or joints may serve as a source of repetitive cytokine stimulation for ECs, a situation in vivo approximated by our it! vitro model utilizing repetitive cytokine doses. Histologic and immunohistochemical studies of chronic inflammation, as is seen in psoriasis, rheumatoid arthritis, or delayed hypersensitivity reactions, are characterized by both perivascular lymphocytic infiltrates and chronic E-selectin expression [12, 13] . The second factor that plays a role in E-selectin persistence is a constituent of human serum or plasma. Repetitive stimulation alone is not sufficient to permit chronic E-selectin expression because ECs become refractory to cytokine effect. Culture oflarge-or small-vessel ECs in the presence of human serum or plasma is permissive for the continuous expression ofE-selectin. In the presence of factors in human serum or plasma, the continuous pulsing of ECs with cytokine in vitro results in persistent E-selectin expression. Evidence from Northern blot analysis demonstrates that the effect occurs at the level of mRNA expression. It is possible that the factor affects cytokine-mediated transcriptional events, mRNA stability, or both. The exact nature of the factor or factors present in human serum and plasma that mediate this effect is not fully characterized. The repetitive stimulation of endothelial cells with plasma fractions separated by gel filtration of plasma demonstrated two peaks of activity, suggesting that either two factors may mediate this effect, or a single small molecular weight factor that may associate with a large carrier protein may be responsible. Characterization of this factor or factors and their interaction with endothelial cells or cytokines is currently under investigation.
This study serves to reconcile in vivo and in vitro data regarding E-selectin induction and persistence on ECs, points to overall similarities between large-and small-vessel ECs in E-selectin regulation, and indicates a critical role for factor(s) in human plasma in this process. Identification of such factor(s) will likely help clarify and better define the mechanisms by which E-selectin expression is induced and maintained in vascular endothelial cells. Furthermore, these data suggest that in vitro models and culture systems that more closely approximate in vivo conditions may be preferable in determining the fine regulation of these critical proteins.
